Filing Details

Accession Number:
0001193805-23-000735
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-16 08:30:37
Reporting Period:
2023-05-15
Accepted Time:
2023-05-16 08:30:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1280776 Immunic Inc. IMUX Pharmaceutical Preparations (2834) 562358443
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1724623 Glenn Whaley 1200 Avenue Of The Americas, Suite 200
New York NY 10036
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-15 5,000 $1.75 25,510 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Includes a purchase of 2,568 shares on 11/30/21 and 2,942 shares on 5/31/22 under the IMUX employee stock purchase plan.